Ascension Health and UNC Rex Healthcare have both contributed to a $35.5m round that will support the development of Bardy's lightweight cardiac monitor.
US-based cardiac monitoring technology developer Bardy Diagnostics has raised $35.5m in a series B round that included the corporate venturing subsidiaries of healthcare providers Ascension Health and UNC Rex Healthcare.
Ascension Ventures and Rex Health Ventures joined venture capital firm River Cities Funds, which led the round, as well as HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures, SV Health Investors and Health Enterprise Partners.
Rik Vandevenne and Garheng Kong, managing directors at River Cities Capital Funds and HealthQuest…
